Immunocore Holdings plc
IMCR$1.60B
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaOXFORDSHIRE
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
2
Next Catalyst
Oct 15, 2026
26wMarket Overview
Stock performance and key metrics
IMCR News
Catalyst Timeline
3 upcoming, 0 past
Drug Pipeline
Brenetafusp
Select Advanced Solid Tumors
Tebentafusp
Advanced Melanoma
IMC-R117C
Cancer
Dacarbazine
Uveal Melanoma
IMCgp100
Uveal Melanoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Brenetafusp | Phase 3 | Select Advanced Solid Tumors | - | - |
Tebentafusp | Phase 3 | Advanced Melanoma | - | - |
IMC-R117C | Phase 2 | Cancer | - | - |
Dacarbazine | Phase 2 | Uveal Melanoma | - | - |
IMCgp100 | Phase 2 | Uveal Melanoma | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply